0 items USD 0.00Search
- Did you mean
- similar
Your search for "biosimilar" gave back 1194 results.
Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. The “...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Biosimilar Testing and Development Services Market The global Biosimilar Testing and Development Services market...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Recombinant Glycosylated Proteins Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR...
Catalog:
GIR
March 2023
Price: USD 4,480.00
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine')...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Neulasta (Pegfilgrastim) and Biosimilar market size was valued at USD 2501.4 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Glycosylated Biosimilars include mA, EPO etc in this report. Publisher' newest research report, the “Glycosylated Biosimilars Industry Forecast...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Innovative Biologics and Biosimilars market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Biosimilars & Follow-on-biologics Market The global Biosimilars & Follow-on-biologics market is...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
